Published by Josh White on 4th December 2019
(Sharecast News) - Cell-based therapeutics and life sciences company MaxCyte has entered into a new development and commercialisation agreement with its existing partner KSQ Therapeutics, it announced on Wednesday.
URL: http://www.digitallook.com/dl/news/story/29951761/...